Zobrazeno 1 - 5
of 5
pro vyhledávání: '"S.F. Jundan"'
Autor:
A. Chouw, G. Facicilia, A.N. Arofah, R. Agustina, Y. Dirgantara, S.F. Jundan, S. Mutia, R.A. Shyallala, C.R. Sartika, M.N. Kirana, M. Subangkit, A. Budiono
Publikováno v:
Cytotherapy. 25:S62-S63
Autor:
Y. Dirgantara, S.F. Jundan, Angliana Chouw, E.D. Pratiwi, A.N. Arofah, G. Facicilia, C.R. Sartika
Publikováno v:
Cytotherapy. 22:S75-S76
Background & Aim Background Stem cell therapy has been considered as a potential strategy in regenerative for the patient with neurological deficits. Mesenchymal Stem/Stromal Cells (MSC) have been extensively investigated as a treatment in stroke. Ho
Autor:
E.R. Utami, E.D. Pratiwi, D. Meutia, C.R. Sartika, J. Riswandani, Y. Dirgantara, S.F. Jundan, Angliana Chouw
Publikováno v:
Cytotherapy. 22:S196-S197
Background & Aim Umbilical cord tissue is a potential source of Mesenchymal Stem Cells (MSCs). These cells have been widely used especially in pre-clinical and clinical applications resulting its various effectiveness. Banking process of umbilical co
Autor:
G.D. Prayitno, E.D. Pratiwi, R. Haifa, Y. Dirgantara, V. Pratama, S.F. Jundan, Angliana Chouw, N. Karina, A.N. Arofah, G. Facicilia, V. Rahmawati, P. Pujowaskito, C.R. Sartika, A.M. Faqih
Publikováno v:
Cytotherapy. 22:S101-S102
Background & Aim Coronary artery disease (CAD) is one of the leading cause of death in the world. Currently, the common therapy for this disease is to use drugs and surgical procedures however the result has been less optimum. Therefore, it is necess
Autor:
Y. Dirgantara, G. Facicilia, M.N. Kirana, C.R. Sartika, S. Mutia, Z. Alifah, S.F. Jundan, Angliana Chouw, A.N. Arofah
Publikováno v:
Cytotherapy. 23:S206